Stillwater Capital Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Stillwater Capital Advisors's MDT Position: Q3 2022 in Review
Stillwater Capital Advisors sold out of Medtronic (MDT) in Q3 2022, closing a stake of 109,876 shares — an estimated $9.86M sold.
Stillwater Capital Advisors first reported a position in MDT in Q1 2016 and held it in 26 quarters. The position peaked at $13.8M in Q3 2021. 1,932 funds tracked by Wall St. Rank hold MDT as of Q3 2022.
- Stillwater Capital Advisors reported no remaining Medtronic position as of Q3 2022 after selling out during the quarter.
- Stillwater Capital Advisors sold 109,876 Medtronic shares in Q3 2022, an estimated $9.86M.
- Stillwater Capital Advisors first reported a position in Medtronic in Q1 2016 and held it in 26 quarters.
- Stillwater Capital Advisors's Medtronic position peaked at $13.8M in Q3 2021.
- 1,932 funds tracked by Wall St. Rank held Medtronic as of Q3 2022.
Based on Stillwater Capital Advisors's 13F filing for Q3 2022, filed 14 Oct 2022.